Improving Environmental Outcomes from Infrastructure by Addressing Permitting Delays
Summary
With the Biden-Harris Administration and Congress together pursuing major infrastructure investments, there is an important question as to how best maximize potential economic and environmental benefits of new infrastructure. Reforming the National Environmental Policy Act (NEPA) is one of the most straightforward and impactful ways to do so. Currently, many major infrastructure projects are delayed due to significant, NEPA-mandated requirements for environmental-impact review. Such delays are frequently exacerbated by vague statutory requirements and exceptional litigation risks. Updated guidance for environmental reviews under NEPA, coupled with strategic judiciary reforms, could expedite infrastructure approval while improving environmental outcomes.
Congress and the Biden-Harris Administration should strive to clarify environmental regulatory requirements and standing for litigation under NEPA. Specific recommended actions include (i) establishing well-defined and transparent processes for public input on governmental environmental-impact statements, (ii) shortening the statute of limitations for litigation under NEPA from two years to 60– 120 days, and (iii) requiring that plaintiffs against governmental records of decision must have previously submitted public input on relevant environmental-impact statements.
This is a bipartisan, commonsense measure to reauthorize the Technology Modernization Fund (TMF) before it expires in September 2026.
Many states are introducing AI policies and task forces, but lack the “AI-native” personnel to build and maintain initiatives. To address this in the short term, states should establish AI Resilience Cohorts to embed early-career technologists in key offices to support state AI initiatives. Right now, Virginia and New Jersey have the opportunity to take […]
We sat down with biomedical research pioneer Lee Hood to talk moonshots, metascience in medicine, and the Human Phenome Initiative.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.